SUNOSI® (Solriamfetol) Pregnancy Registry
NCT06413420
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The SUNOSI (solriamfetol) Pregnancy Registry is a US- and Canada-based prospective, observational study to evaluate the safety of solriamfetol exposure during pregnancy in women with a diagnosis of narcolepsy or obstructive sleep apnea (OSA).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Narcolepsy
- Obstructive Sleep Apnea
- Pregnant Women and Their Offspring
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Any age
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- Axsome Therapeutics, Inc.
- Last updated on ClinicalTrials.gov
- October 5, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
North Carolina · 2
- Evidera, a PPD business unit · Morrisville, NC
- PPD, Inc. · Wilmington, NC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.